NCT03384290View on ClinicalTrials.gov

Study of a Single Dose of PRS-060 Administered by Oral Inhalation or IV Infusion in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

December 8, 2017

Primary Completion Date

October 11, 2018

Study Completion Date

October 11, 2018

Conditions
Healthy Subjects
Interventions
DRUG

PRS-060

Drug

DRUG

Placebo

PRS-060 Matching Placebo

Trial Locations (1)

3004

Nucleus Network Limited, Melbourne

All Listed Sponsors
lead

Pieris Australia Pty Ltd

INDUSTRY

NCT03384290 - Study of a Single Dose of PRS-060 Administered by Oral Inhalation or IV Infusion in Healthy Subjects | Biotech Hunter | Biotech Hunter